IRAK-4 inhibitors (Merck Serono)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameIRAK-4 inhibitors (Merck Serono)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 inhibitors

TargetsInterleukin-1 receptor-associated kinase 4

Therapy Area/IndicationsInflammationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck Serono Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMerck Serono Sa

Active IndicationsN/A

Inactive IndicationsInflammationAutoimmune Diseases

ATC CodeN/A